Skip to main content

Table 3 CES-D: Responder rates at follow-ups

From: Anthroposophic therapy for chronic depression: a four-year prospective cohort study

Follow-up month CES-D improved from baseline   CES-D improved from baseline by ≥ 50%   CES-D ≤ 23 (not depressed)  
  Proportion of evaluable patients Proportion of all patients Proportion of evaluable patients Proportion of all patients Proportion of evaluable patients Proportion of all patients
  N (%) N (%) N (%) N (%) N (%) N (%)
3 59/67 (88%) 59/79 (75%) 21/67 (31%) 21/79 (27%) 39/67 (58%) 39/79 (49%)
6 60/69 (87%) 60/79 (79%) 27/69 (39%) 27/79 (34%) 47/69 (68%) 47/79 (59%)
12 54/62 (87%) 54/79 (68%) 32/62 (52%) 32/79 (41%) 41/62 (66%) 41/79 (52%)
18 50/59 (85%) 50/79 (63%) 33/59 (56%) 33/79 (42%) 41/59 (69%) 41/79 (52%)
24 54/60 (90%) 54/79 (68%) 31/60 (52%) 31/79 (41%) 40/60 (67%) 40/79 (51%)
48 43/48 (90%) 43/79 (54%) 28/48 (56%) 28/79 (35%) 37/48 (77%) 37/79 (47%)
  1. Patients enrolled after 1.1.99. CES-D: Center for Epidemiological Studies Depression Scale, German version